Pharmacists' perceived barriers towards delivering their emergency roles during the COVID-19 pandemic and perceived policymakers' responsibilities.
Coronavirus
Educational institutes
Faculty of Pharmacy
Jordan
Pandemics
Pharmaceutical association
Pharmacy educators
Journal
Journal of pharmaceutical policy and practice
ISSN: 2052-3211
Titre abrégé: J Pharm Policy Pract
Pays: England
ID NLM: 101627192
Informations de publication
Date de publication:
2020
2020
Historique:
received:
28
05
2020
accepted:
12
08
2020
entrez:
25
9
2020
pubmed:
26
9
2020
medline:
26
9
2020
Statut:
epublish
Résumé
In March 2020, the World Health Organization (WHO) declared the coronavirus infectious disease as a pandemic referred to as COVID-19. As an essential service, community pharmacists have been enacting a key role in patient counseling and supply of essential medicines and protective equipment. To investigate pharmacists' perspectives of the role of educational institutes and professional pharmacy organizations in supporting them to take on roles during COVID-19 pandemic and to identify barriers to be able to support themselves and their patients. This descriptive mixed-method study was conducted via a cross-sectional online survey distributed to pharmacists/pharmacy students in Jordan during the COVID-19 outbreak (15-30 March 2020) using an online questionnaire, followed by an online focus group. Questionnaire items related to participants' perspectives in being prepared for and supported in their roles during the COVID-19 pandemic, and items were tested for face validity. Data were descriptively analyzed using the Statistical Package for the Social Sciences and triangulated with focus group findings. Considering that fear and anxiety are a consequence of mass social distancing/quarantine, study participants ( Most participants believed that pharmacy educators and pharmaceutical associations have a role in preparing them to deal with the COVID-19 pandemic through online educational workshops/webinars. Online education on mental healthcare is specifically needed.
Identifiants
pubmed: 32974036
doi: 10.1186/s40545-020-00254-y
pii: 254
pmc: PMC7506204
doi:
Types de publication
Journal Article
Langues
eng
Pagination
62Informations de copyright
© The Author(s) 2020.
Déclaration de conflit d'intérêts
Competing interestsThe authors declare that they have no competing interests.
Références
Glob J Qual Saf Healthc. 2020 Jul 8;3(3):109-114
pubmed: 37275599
Health Secur. 2018 Jul/Aug;16(4):262-273
pubmed: 30133375
Respir Care. 2014 Nov;59(11):1716-25
pubmed: 24962222
Pharm Pract (Granada). 2020 Jan-Mar;18(1):1744
pubmed: 32256897
Int J Pharm Pract. 2020 Apr;28(2):173-181
pubmed: 32176415
J Public Health Manag Pract. 2011 Sep-Oct;17(5):439-48
pubmed: 21788782
Health Secur. 2018 Mar/Apr;16(2):108-118
pubmed: 29570363
Res Social Adm Pharm. 2021 Jan;17(1):1813-1818
pubmed: 32278766
Res Social Adm Pharm. 2021 Feb;17(2):480-482
pubmed: 32241695
Am J Respir Crit Care Med. 2020 Feb 15;201(4):P7-P8
pubmed: 32004066
Lancet. 2020 Mar 28;395(10229):1047-1053
pubmed: 32199075
Lancet. 2020 Mar 14;395(10227):912-920
pubmed: 32112714
Eur Heart J Acute Cardiovasc Care. 2020 Apr;9(3):241-247
pubmed: 32342698
Res Social Adm Pharm. 2021 Jan;17(1):2027-2031
pubmed: 32273253
BMJ. 2020 Mar 18;368:m1090
pubmed: 32188598
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Infect Dis Poverty. 2020 Mar 17;9(1):29
pubmed: 32183901
Res Social Adm Pharm. 2021 Jan;17(1):1988-1989
pubmed: 32224133
Res Social Adm Pharm. 2020 Jan;16(1):90-95
pubmed: 30948214
Res Social Adm Pharm. 2021 Mar;17(3):514-522
pubmed: 32360181
Drugs Ther Perspect. 2020;36(5):215-217
pubmed: 32218651